Further in vitro and in vivo studies are necessary to confirm this causal role and to uncover the mechanisms through which rs2522057 may regulate IRF1, RAD50, and SCL22A5 expression via CARINH, ultimately affecting cancer development. The gene discussed is IRF1; the disease is cancer.